Reliq Health Technologies Inc.
RQHTF · OTC
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $8,552 | $1,462 | $1,143 | $182 |
| % Growth | 484.9% | 27.9% | 528.4% | – |
| Cost of Goods Sold | $3,251 | $7,260 | $7,524 | $5,844 |
| Gross Profit | $5,301 | -$5,798 | -$6,381 | -$5,662 |
| % Margin | 62% | -396.5% | -558.3% | -3,112.7% |
| R&D Expenses | $2,222 | $1,732 | $1,724 | $5,151 |
| G&A Expenses | $10,028 | $10,112 | $8,817 | $7,330 |
| SG&A Expenses | $10,521 | $10,627 | $9,171 | $7,605 |
| Sales & Mktg Exp. | $493 | $516 | $353 | $274 |
| Other Operating Expenses | $889 | $178 | -$6,052 | -$34 |
| Operating Expenses | $13,632 | $12,537 | $4,843 | $7,823 |
| Operating Income | -$8,296 | -$11,633 | -$11,224 | -$13,485 |
| % Margin | -97% | -795.6% | -982% | -7,413.2% |
| Other Income/Exp. Net | $160 | -$101 | $34 | $301 |
| Pre-Tax Income | -$8,171 | -$11,781 | -$11,122 | -$13,004 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8,171 | -$11,781 | -$11,122 | -$13,004 |
| % Margin | -95.5% | -805.7% | -973.1% | -7,148.8% |
| EPS | -0.045 | -0.075 | -0.082 | -0.11 |
| % Growth | 40.2% | 9.4% | 25.2% | – |
| EPS Diluted | -0.045 | -0.075 | -0.082 | -0.11 |
| Weighted Avg Shares Out | 183,086 | 157,891 | 135,219 | 118,414 |
| Weighted Avg Shares Out Dil | 183,086 | 157,891 | 135,219 | 118,414 |
| Supplemental Information | – | – | – | – |
| Interest Income | $77 | $0 | $0 | $0 |
| Interest Expense | $35 | $47 | $36 | $0 |
| Depreciation & Amortization | $115 | $75 | $445 | $634 |
| EBITDA | -$8,020 | -$11,507 | -$10,779 | -$12,851 |
| % Margin | -93.8% | -787% | -943% | -7,064.6% |